Top 3 Health Care Stocks That Are Set To Fly This Quarter

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

Here's the latest list of major oversold players in this sector, having an RSI near or below 30.

BIMI Holdings Inc (NASDAQ:BIMI)

• On May 20, BIMI announced the receipt of a delinquency compliance alert notice from Nasdaq.  The company's stock fell around 68% over the past five days and has a 52-week low of $0.24.
• RSI Value: 24.62
• BIMI Price Action: Shares of BIMI Holdings closed at $0.42 on Wednesday.
• Benzinga Pro’s charting tool helped identify the trend in DXCM stock.

Edwards Lifesciences Corp (NYSE:EW) 

• On July 24, Edwards Lifesciences reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired JenaValve and Endotronix.. The company's stock fell around 30% over the past month. It <a href=”https://www.benzinga.com/quote/EW”><em> has a 52-week low </em></a> of $58.93.
• RSI Value: 22.55
• EW Price Action: Shares of Edwards Lifesciences closed at $63.05 on Wednesday.
• Benzinga Pro’s real-time newsfeed alerted to latest EW news.

Merck & Co Inc (NYSE:MRK)

• Merck reported better-than-expected second-quarter earnings and sales results on Tuesday. The company posted quarterly sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28, a shift from an EPS loss of $(2.06), beating the consensus of $2.15. The company's shares fell around 12% over the past month and has a 52-week <a href=”https://www.benzinga.com/quote/MRK”><em> low of $99.14.</em></a>
• RSI Value: 28.20
• MRK Price Action: Shares of Merck rose 0.1% to close at $113.13 on Wednesday.

Read More:

• Nasdaq Settles Higher As Nvidia Records Best Session Since February: Fear & Greed Index Now In ‘Neutral’ Zone As Investor Sentiment Improves